Clincosm LogoSign in Get a demo

recurrent glioma

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023

Healthy Volunteers, Recurrent Glioma, Brain Metastases From Extra-cranial Solid Tumors Trial ([F-18]MeFAMP PET)

Not yet recruiting
  • Healthy Volunteers
  • +2 more
  • [F-18]MeFAMP PET
  • (no location specified)
Jan 4, 2023

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

Not yet recruiting
  • Glioblastoma
  • +3 more
  • CARv3-TEAM-E T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Dec 13, 2022

Advanced Solid Tumor, Recurrent Glioma, CNS Lymphoma Trial in United States (PRT811)

Active, not recruiting
  • Advanced Solid Tumor
  • Recurrent Glioma
  • Denver, Colorado
  • +9 more
Dec 16, 2022

Glioma, Recurrent Glioma Trial in Shanghai (Hypofractionated Stereotactic Radiotherapy, Bevacizumab)

Active, not recruiting
  • Glioma
  • Recurrent Glioma
  • Shanghai, Shanghai, China
    CyberKnife Center, Department of Neurosurgery, Huashan Hospital
Nov 3, 2022

Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)

Recruiting
  • Low-grade Glioma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 19, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +32 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +124 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +30 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +123 more
Aug 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Recurrent Glioblastoma, Recurrent Astrocytoma, Recurrent Oligodendroglioma Trial in Oklahoma City (Niraparib)

Recruiting
  • Recurrent Glioblastoma
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jul 20, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Glioma, Malignant Glioma, Recurrent Glioma Trial in Los Angeles (Biospecimen Collection, Diagnostic Imaging, Magnetic Resonance

Recruiting
  • Glioma
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 24, 2021

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)

Recruiting
  • Malignant Glioma
  • Recurrent Glioma
  • personalized vaccine
  • Beijing, Beijing, China
    Xuanwu Hospital, Capital Medical University
Jun 26, 2021

Recurrent Glioma Trial in Zhengzhou (Apatinib)

Recruiting
  • Recurrent Glioma
  • Zhengzhou, Henan, China
    Department of Neurosurgery, First Affiliated Hospital of Zhengzh
Feb 5, 2021

Recurrent Brian Glioma:Prognostic Factors and Outcome

Unknown status
  • Recurrent Glioma
  • Glioma, Malignant
    • Assiut, Egypt
      Assuit University Hospitals
    Sep 18, 2020

    Recurrent Glioma Trial in Salt Lake City (Bevacizumab, Minocycline, Radiation)

    Completed
    Has Results
    • Recurrent Glioma
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Aug 9, 2019

    Recurrent Glioma, High-grade Meningioma, Brain Metastasis Trial in Philadelphia (drug, radiation, procedure)

    Terminated
    • Recurrent Glioma
    • +2 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Dec 8, 2016